| Literature DB >> 34934441 |
Jianmin Guo1, Yu Yuan1,2, Lingli Zhang1,2, Miao Wang1, Xiaoyang Tong1, Lifei Liu1, Miao Zhang1, Hui Li1, Xi Chen1,3, Jun Zou1.
Abstract
Physical activity or exercise are known to promote bone formation and decrease bone resorption to maintain skeletal and bone health both in animal models and in humans with osteoporosis. Previous studies have indicated that long non-coding RNAs (lncRNAs) are able to regulate bone metabolism. Therefore, the present study aimed to evaluate whether lncRNAs responded to exercise by regulating the balance of bone metabolism in order to prevent osteoporosis. To meet this end, ovariectomized mice were used in the present study to establish an osteoporosis model. The exercise treatment groups were subjected to 9 weeks of treadmill running exercise in 4 weeks of the operation was performed Femurs were collected to measure bone mineral density, bone mass, bone formation and resorption. The expression levels of lncRNAs were subsequently measured using microarray and gene function analyses. The pairwise comparison results [ovariectomy (OVX) vs. OVX + exercise (EX); OVX vs. SHAM; SHAM vs. SHAM + EX; OVX + EX vs. SHAM + EX] of the gene microarray analysis revealed that the expression of 2,424 lncRNAs (1718 upregulated and 706 downregulated) were significantly altered in the mouse femurs following treadmill running. Gene Ontology (GO) analysis, incorporating the GO annotations 'biological processes', 'molecular function' and 'cellular components', of osteoporosis revealed that the VEGF, mTOR and NF-κB signaling pathways were potential targets of the lncRNAs. Moreover, it was possible to predict the target microRNAs (miRNAs) of six lncRNAs (LOC105246953, LOC102637959, NONMMUT014677, NONMMUT027251, ri|D130079K21|PX00187K16|1491 and NONMMUT006626), which suggested that the underlying mechanism by which lncRNAs respond to exercise involved bone regulation via lncRNA-miRNA sponge adsorption. Overall, these results suggested that the treadmill running exercise did regulate lncRNA expression in the bone, and that this was involved in the prevention of osteoporosis. Copyright: © Guo et al.Entities:
Keywords: exercise; long non-coding RNA; microRNA; osteoporosis
Year: 2021 PMID: 34934441 PMCID: PMC8649853 DOI: 10.3892/etm.2021.10993
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Figure 1Effects of exercise and/or ovariectomy on body weight, BMD and bone biomechanics. (A) Outline of the exercise protocol. (B) Body weight of mice in each group (n=11 mice). **P<0.01, the SHAM group or the OVX + EX group vs. the OVX group. (C) BMD of mice in each group (n=8). (D) Effect of exercise on bone ultimate force (n=8 mice). (E) Effect of exercise on bone yield stress (n=8). (F) Effect of exercise on bone elastic modulus (n=8). *P<0.05; **P<0.01. OVX, bilateral ovariectomy group; OVX + EX, bilateral ovariectomy and exercise group; SHAM, sham operation group; SHAM + EX, sham operation and exercise group. BMD, bone mineral density.
Figure 2Results of µCT and effect of exercise on bone histomorphometric parameters. (A) Representative µCT images demonstrating the three-dimensional trabecular architecture in mouse femur. (B) Representative images of mouse bones which were labeled with subcutaneously injected calcein (5 µl/g) at days 1 and 8. (C) Trabecular bone mass (BV/TV), (D) Tb.Sp, (E) Tb.Th and (F) Tb.N of mouse femur was determined using µCT. (G) Effect of exercise on BFR/BV. (H) Effect of exercise on the MAR. *P<0.05; **P<0.01. OVX, bilateral ovariectomy group; OVX + EX, bilateral ovariectomy and exercise group; SHAM, sham operation group; SHAM + EX, sham operation and exercise group; µCT, microcomputed tomography; MAR, mineral apposition rate; BV/TV, bone volume/tissue volume; BFR/BV, bone formation rate/bone volume; Tb.N, trabecular number; Tb.Sp, trabecular separation. Tb.Th, trabecular thickness.
Figure 3Effect of exercise on the expression profiles of differentially expressed lncRNAs in the bone of mice. Hierarchical cluster of lncRNA expression profiles: (A) OVX vs. SHAM, (B) SHAM + EX vs. SHAM, (C) OVX + EX vs. SHAM + EX and (D) OVX vs. OVX + EX. (E and F) Co-expression of lncRNAs in the OVX + EX and SHAM groups that are (E) upregulated or (F) downregulated compared with the OVX group. (G and H) Co-expression of lncRNAs in the OVX + EX and SHAM groups that are (G) upregulated or (H) downregulated compared with the SHAM group. OVX, bilateral ovariectomy group; OVX + EX, bilateral ovariectomy and exercise group; SHAM, sham operation group; SHAM + EX, sham operation and exercise group; lncRNA, long non-coding RNA.
Figure 4GO and KEGG pathway analysis of the biological functions of genes co-expression with differentially expressed lncRNAs. Top 10 (A) ‘cellular component’, (B) ‘biological process’ and (C) ‘molecular function’ terms of the differentially expressed lncRNAs in the OVX group compared with the OVX + EX group. (D) Top 10 pathways of the differentially expressed lncRNAs in the OVX group compared with the OVX + EX group. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; lncRNA, long non-coding RNA.
Fold changes of the co-expressed lncRNAs in the OVX + EX and SHAM groups that are upregulated or downregulated compared with the OVX group.
| A, Upregulated lncRNAs | ||
|---|---|---|
| Gene symbol | FC of OVX + EX | FC of SHAM |
| Gm35194 | 2.15 | 2.37 |
| LOC105246953 | 2.44 | 2.33 |
| LOC102637959 | 2.08 | 2.07 |
| Gm30392 | 2.64 | 2.72 |
| NONMMUT014677 | 2.51 | 2.08 |
| NONMMUT016039 | 2.14 | 3.17 |
| NONMMUT027251 | 2.61 | 3 |
| NONMMUT067810 | 2.37 | 4.1 |
| ri|7330424C03|PX00650H15|3890 | 2.04 | 2.14 |
| ri|8430440M04|PX00025O03|1121 | 2.05 | 2.49 |
| ri|9430019C24|PX00108O13|1178 | 2.11 | 2.42 |
| ri|A230069F12|PX00129C15|2187 | 2.4 | 2.24 |
| ri|A430104H18|PX00064B06|3523 | 2.05 | 2.39 |
| ri|B020006F18|PX00325E01|1577 | 2.87 | 3.02 |
| ri|F930011C10|PL00010K14|3597 | 2.23 | 3 |
| B, Downregulated lncRNAs | ||
| Gene symbol | FC of OVX + EX | FC of SHAM |
| NONMMUT006626 | 2.17 | 2.54 |
| ri|D130079K21|PX00187K16|1491 | 2 | 2.35 |
| uc.mouse.68 | 3.87 | 2.75 |
OVX, ovariectomy; EX, exercise; lncRNA, long non-coding RNA; FC, Fold change vs. the OVX group.
miRNAs targeted by the dysregulated lncRNAs.
| A, Upregulated expression | |
|---|---|
| lncRNA | miRNA target sites |
| LOC105246953 | mmu-miR-215-3p, mmu-miR-670-3p, mmu-miR-1186, mmu-miR-1186b |
| LOC102637959 | mmu-miR-15a-5p, mmu-miR-706, mmu-miR-466i-5p, mmu-miR-1187, mmu-miR-1195 |
| NONMMUT014677 | mmu-miR-669c-3p, mmu-miR-466f-3p, mmu-miR-466k, mmu-miR-574-5p, mmu-miR-466i-5p, mmu-miR-466i-3p, mmu-miR-1187, mmu-miR-466m-3p, mmu-miR-3095-3p |
| NONMMUT027251 | mmu-miR-669c-3p, mmu-miR-466f-3p, mmu-miR-574-5p, mmu-miR-466i-5p, mmu-miR-466i-3p, mmu-miR-1187, mmu-miR-466k, mmu-miR-466m-3p, mmu-miR-3095-3p |
| B, Downregulated expression | |
| lncRNA | miRNA target sites |
| ri|D130079K21|PX00187K16|1491 | mmu-miR-302b-3p, mmu-miR-669c-3p, mmu-miR-466i-3p, mmu-miR-669h-3p, mmu-miR-466m-3p, mmu-miR-466q |
| NONMMUT006626 | mmu-miR-328-3p, mmu-miR-3473b, mmu-miR-5128, mmu-miR-185-3p, mmu-miR-221-5p, mmu-miR-221-3p, mmu-miR-452-3p, mmu-miR-466i-5p, mmu-miR-1187, mmu-miR-3473 |
lncRNA, long non-coding RNA; miR/miRNA, microRNA; mmu, Mus musculus.